Literature DB >> 13878274

The appearance of pyrimethamine resistance in Plasmodium falciparum following self-medication by a rural community in Ghana.

L J CHARLES, H J VAN DER KAAY, I H VINCKE, J BRADY.   

Abstract

During the preparatory phase of the Malaria Eradication Pilot Project in Ghana, a weekly pyrimethamine regimen was instituted at two hyperendemic villages, primarily to assess the reliability of self-administration techniques under local conditions.After initial supervised individual administrations, weekly distribution of family drug requirements was made to a responsible member of each household by volunteer community leaders.Although parasite rates fell from 71% to 6.5% after four weeks, recurrence of Plasmodium falciparum parasitaemia was observed by the 37th week. Resistance in that species was confirmed, associated with successful sporogony in Anopheles gambiae, after supervised pyrimethamine treatment equivalent to twice the routine dosage.Emergence of this high-grade drug resistance was attributable to irregular self-administration by the local population of the tablets collected for each household. It was therefore concluded that under the conditions obtaining, self-medication was not a reliable method for mass distribution of pyrimethamine.

Entities:  

Keywords:  ANTIMALARIALS/pharmacology

Mesh:

Substances:

Year:  1962        PMID: 13878274      PMCID: PMC2555651     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  The appearance of P. falciparum resistant to pyrimethamine in a northern Nigerian village.

Authors:  H M ARCHIBALD
Journal:  West Afr Med J       Date:  1960-02

2.  Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals.

Authors:  D F CLYDE; G T SHUTE
Journal:  Trans R Soc Trop Med Hyg       Date:  1957-11       Impact factor: 2.184

3.  Resistance of East African varieties of Plasmodium falciparum to pyrimethamine.

Authors:  D F CLYDE; G T SHUTE
Journal:  Trans R Soc Trop Med Hyg       Date:  1954-11       Impact factor: 2.184

4.  [Medicinal prevention of malaria in rural zones].

Authors:  I H VINCKE
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

  4 in total
  7 in total

Review 1.  The changing limits and incidence of malaria in Africa: 1939-2009.

Authors:  Robert W Snow; Punam Amratia; Caroline W Kabaria; Abdisalan M Noor; Kevin Marsh
Journal:  Adv Parasitol       Date:  2012       Impact factor: 3.870

Review 2.  New answers through chemotherapy?

Authors:  W Peters
Journal:  Experientia       Date:  1984-12-15

Review 3.  Mass drug administration for malaria.

Authors:  Eugenie Poirot; Jacek Skarbinski; David Sinclair; S Patrick Kachur; Laurence Slutsker; Jimee Hwang
Journal:  Cochrane Database Syst Rev       Date:  2013-12-09

4.  Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors.

Authors:  Carolyn K Dong; Vishal Patel; Jimmy C Yang; Jeffrey D Dvorin; Manoj T Duraisingh; Jon Clardy; Dyann F Wirth
Journal:  Bioorg Med Chem Lett       Date:  2008-11-24       Impact factor: 2.823

5.  Identification and characterization of small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.

Authors:  Vishal Patel; Michael Booker; Martin Kramer; Leila Ross; Cassandra A Celatka; Leah M Kennedy; Jeffrey D Dvorin; Manoj T Duraisingh; Piotr Sliz; Dyann F Wirth; Jon Clardy
Journal:  J Biol Chem       Date:  2008-10-08       Impact factor: 5.157

Review 6.  Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review.

Authors:  Bipin Adhikari; Nicola James; Gretchen Newby; Lorenz von Seidlein; Nicholas J White; Nicholas P J Day; Arjen M Dondorp; Christopher Pell; Phaik Yeong Cheah
Journal:  Malar J       Date:  2016-11-02       Impact factor: 2.979

Review 7.  Multidrug-resistant malaria and the impact of mass drug administration.

Authors:  Janie Anne Zuber; Shannon Takala-Harrison
Journal:  Infect Drug Resist       Date:  2018-03-01       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.